Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Identify which cards offer the highest cash back. This guide will help you maximize your rewards on everyday spending.
26,208 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Arm Holdings has surged 104% year-to-date, with the AI pivot and AGI CPU driving demand. Smart money sits near a spec...
Retail investors may finally gain access to SpaceX’s IPO as account minimums being lowered promise a wider door. This...
The crypto market braced for headlines as Circle faced talk of an open USD threat. Analysts argue the pullback in CRC...
Markets opened lower as geopolitical tensions with Iran intensified, sending risk assets lower while energy and defen...
Federal bank regulators announced a three-part plan to revise capital rules for mortgage assets, aiming to lift origi...
A sweeping shift in government-backed tech funding is changing how investors value IBM and Intel. Taxpayers, once dis...
U.S. equities sit near record highs as AI spending fuels gains, but a growing chorus on Wall Street warns that federa...
Public moments can shift finances as quickly as headlines change. This article uses adele’s rare return sparks as a s...
Analysts upgrade CrowdStrike ahead of earnings, citing modest guidance risk and a software sector pullback that has w...
In his first week as Disney’s leader, Josh D’Amaro confronts three major headwinds that could set the tone for his te...
A big institutional purchase in ENOV has investors buzzing. This article breaks down what the move could signal, how ...